Newswise, February 10, 2016--Boomer years have seen an increase in
those suffering from allergies, including baby boomers. And because older
people tend to have additional chronic diseases, diagnosis and management of
allergic rhinitis (hay fever) can be a challenge. A new study shows
immunotherapy (allergy shots) reduced symptoms by 55 percent after three years
of therapy, and decreased the amount of medication needed for relief of
symptoms by 64 percent.
The study, in the Annals of Allergy, Asthma and
Immunology, the scientific publication of the American College of Allergy,
Asthma and Immunology (ACAAI), randomly sorted 60 hay fever sufferers, aged 65
to 75 years, into two groups. The first group received allergy shots for three
years, and the second group received a placebo.
“Older people who suffer from hay fever may have health
challenges that younger people do not,” said allergist Ira Finegold, MD, ACAAI
past president. “Hay fever is often ignored in older patients as a less
significant health problem because of diseases such as asthma, coronary heart
disease, depression and high blood pressure. Also, some baby boomers might not
realize they have allergies, and their physicians might not suggest allergy
shots. The research indicated that allergy shots were extremely effective for
this group.”
Although the guidelines for the diagnosis and treatment of
allergic diseases rarely focus on older patients, according to the Polish
study, hay fever is more common in patients over 65 years of age.
“It’s important that allergy treatment methods commonly used
in young people are also investigated for use in older patients,” said
allergist Gailen Marshall, MD, PhD, Editor-in-Chief, Annals of Allergy, Asthma
and Immunology. “More and more allergists are expanding the age limit for
allergy shots as the baby boomer generation enters their senior years. Although
there are no doubts about the effectiveness of allergy shots for both adults
and children, there hasn’t been much research until now in older patients.”
The study authors state the results of the study indicate an
aging immune system doesn’t significantly influence the effectiveness of
immunotherapy.
About ACAAI
The ACAAI is a professional medical organization of more than 6,000 allergists-immunologists and allied health professionals, headquartered in Arlington Heights, Ill. The College fosters a culture of collaboration and congeniality in which its members work together and with others toward the common goals of patient care, education, advocacy and research. ACAAI allergists are board-certified physicians trained to diagnose allergies and asthma, administer immunotherapy, and provide patients with the best treatment outcomes. For more information and to find relief, visit AllergyandAsthmaRelief.org. Join us onFacebook, Pinterest and Twitter.
The ACAAI is a professional medical organization of more than 6,000 allergists-immunologists and allied health professionals, headquartered in Arlington Heights, Ill. The College fosters a culture of collaboration and congeniality in which its members work together and with others toward the common goals of patient care, education, advocacy and research. ACAAI allergists are board-certified physicians trained to diagnose allergies and asthma, administer immunotherapy, and provide patients with the best treatment outcomes. For more information and to find relief, visit AllergyandAsthmaRelief.org. Join us onFacebook, Pinterest and Twitter.
No comments:
Post a Comment